• A Profile in the Art of Clinical Trial Analysis

    The Economist | Over a 40-year career as a biostatistician specializing in the design of clinical trials, Susan Ellenberg has helped to mainstream and refine such essential principles as full data retention, surrogate endpoints, partnerships with patient advocacy groups, and interim analyses.

    Mar 9, 2015

  • Wearables for Chronic Illnesses: Challenges and Opportunities in the Market

    Clinical Informatics News | Contributed Commentary | The U.S. spends more on healthcare than most other industrialized countries yet consistently ranks well below them in health outcomes. Nearly 85% of our health care dollars are spent on caring for chronic diseases, the most common, costly, and preventable of all health problems. These include diabetes, heart disease, and chronic pain from various causes; all of which require investments in monitoring, compliance, and behavioral change.  Could wearable technologies uniquely designed to help manage chronic disease provide a solution?

    Mar 5, 2015

  • Association for Molecular Pathology Releases Model for Pricing Genomic Tests

    Clinical Informatics News | The AMP has published a series of models estimating the cost and value of various testing procedures that involve broad next-generation sequencing of DNA samples and bioinformatics pipelines for analyzing the results.

    Mar 5, 2015

  • Medical Informatics World 2015 Preview

    Clinical Informatics News | The 2015 Medical Informatics World Conference will meet in Boston this May 4-5 to offer health IT professionals a chance to share their experiences in an evolving clinical landscape.

    Mar 4, 2015

  • Fat Chance FDA Chastises Orexigen for Disclosing Interim Trial Data

    Pharmalot | The FDA has publicly chastised a drug maker for unexpectedly disclosing interim study data for a medicine in a filing with the U.S. Securities and Exchange Commission.

    Mar 4, 2015

  • February Clinical News and Product Briefs

    Clinical Informatics News | Clinical news and product releases from around the industry, including the first regulatory-cleared non-invasive prenatal test in Europe, and the resignation of Myriad Genetics' CEO.

    Mar 3, 2015

  • Clinical Informatics News Honors Best Practices from ePharmaSolutions, Dabo Health, CSM

    Clinical Informatics News | The winners of Clinical Informatics News’ Best Practices Awards were announced yesterday at the 2015 Summit for Clinical Ops Executives, SCOPE, in Orlando. Three grand prizes were awarded recognizing organizations’ outstanding use of information technology to improve patient services, clinical operations, and clinical trial management. Six additional companies were named finalists. 

    Feb 27, 2015

  • ERT Acquires PHT

    Clinical Informatics News | ERT announced this morning that it has acquired PHT Corporation. Financial terms of the transaction were not disclosed, and the transaction is subject to regulatory review and is expected to close within the next several weeks.

    Feb 27, 2015

  • Pharma Proposes its own Plan for Updating Safety Warnings on Generics

    WSJ | The FDA has proposed a rule to allow generic drug makers to update product labels on their medicines when they learn of safety risks, but the pharmaceutical industry has countered with its own proposal.

    Feb 27, 2015

  • DrugDev on the Investigator Registry, Designing Innovative Solutions

    Clinical Informatics News | DrugDev has been selected by TransCelerate BioPharma to develop and host the Investigator Registry, which will bring together investigator information in one place with one identifier.

    Feb 26, 2015

  • Healthcare on the Hill: Washington's Efforts to Support Clinical Research

    Clinical Informatics News | In an effort to heal the ailing American health care system, the 114th Congress is expected to consider several bipartisan healthcare bills this year, ranging from more efficient discovery and development processes to patient input expansion. 

    Feb 23, 2015